| Followers | 21 |
| Posts | 1508 |
| Boards Moderated | 1 |
| Alias Born | 10/23/2014 |
Thursday, February 04, 2016 9:52:53 AM
$GOVX DD
GeoVax’s Senior Vice President of Research and Development, Farshad Guirakhoo, PhD, will lead the company’s effort in developing a Zika virus vaccine. Dr. Guirakhoo played pivotal roles in the development and licensure of human vaccines against Flaviviruses including dengue and Japanese encephalitis. His extensive experience and expertise with Flavivirus vaccine development gives the company an advantage over competitors and will shorten the time until a Zika vaccine can be brought to market by GeoVax and its partners.
Dr. Guirakhoo stated, “I am thrilled to have the opportunity to develop a Zika vaccine. We will draw on lessons learned on the decades-long path to a successful dengue vaccine and develop a vaccine against Zika in the shortest time possible.”
https://hstalks.com/t/3056/replication-competent-viral-vectors/?biosci
GeoVax’s Senior Vice President of Research and Development, Farshad Guirakhoo, PhD, will lead the company’s effort in developing a Zika virus vaccine. Dr. Guirakhoo played pivotal roles in the development and licensure of human vaccines against Flaviviruses including dengue and Japanese encephalitis. His extensive experience and expertise with Flavivirus vaccine development gives the company an advantage over competitors and will shorten the time until a Zika vaccine can be brought to market by GeoVax and its partners.
Dr. Guirakhoo stated, “I am thrilled to have the opportunity to develop a Zika vaccine. We will draw on lessons learned on the decades-long path to a successful dengue vaccine and develop a vaccine against Zika in the shortest time possible.”
https://hstalks.com/t/3056/replication-competent-viral-vectors/?biosci
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
